IGFBP1 and metabolic syndrome: The inclusion of one or more pro-inflammatory cytokines that are associated with the metabolic syndrome, e.g., CRP, and/or likely to increase IGFBP-1 production, e.g., IL-6, could help in assessment at the individual level.